India has resumed exports of the new coronavirus vaccine, which had been suspended due to the explosive spread of the infection in the country, for the first time in about half a year, saying that the infection situation has improved.
The number of people infected with the new coronavirus in India has peaked at over 400,000 per day in May and has been declining sharply, and economic activity continues to resume.
In response to this situation, a spokesman for the Indian Ministry of Foreign Affairs announced at a press conference on the 14th that it had resumed exports of the new coronavirus vaccine for the first time in about half a year.
Export destinations are neighboring countries Nepal, Bangladesh, Myanmar, and Iran.
India was originally active in the manufacture of pharmaceuticals and exported vaccines mainly to neighboring countries, but due to the spread of domestic infections, it has stopped supplying vaccines overseas since late April.
India emphasizes its commitment to global infection control through vaccine exports, with Japan, the United States, Australia and India's quad-four countries holding 1.2 billion joint statements at the September summit. In addition to providing safe and effective vaccines that exceed the above, it will secure expansion of production.